FORMEDIX RYZE
LIVE

Serial Number

90132747

Owner

Formedix Limited

Attorney

Carrie Webb Olson

Filing Date

Aug 24, 2020

Add to watchlist:

No watchlists yet
View on USPTO

FORMEDIX RYZE Trademark

Serial Number: 90132747 • Registration: 6482181

FORMEDIX RYZE is a trademark filed by Formedix Limited on August 24, 2020. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Formedix Limited (3 trademarks)

The Connect Building
Glasgow G22DH , SC

Entity Type: 99

Trademark Details

Filing Date

August 24, 2020

Registration Date

September 14, 2021

Published for Opposition

June 1, 2021

Goods & Services

Providing training services to enable pharmaceutical companies, biotechnology companies, medical device manufacturers, and contract research organizations to use clinical metadata management software platforms for managing clinical trial metadata and clinical trial data; providing training services to enable pharmaceutical companies, biotechnology companies, medical device manufacturers, and contract research organizations to collect the required clinical data and meet the regulations and standards required by international and government agencies for data collection, tabulation, analysis, and submission for clinical trials; providing training services in relation to the use of clinical metadata management computer software for use in relation to clinical trials; providing training services in relation to the use of clinical management computer software for use in relation to clinical trials; all of the aforesaid training services being used in relation to clinical trials only

On-line retail ordering services featuring clinical metadata management computer software for use in relation to clinical trials, clinical management computer software for use in relation to clinical trials, computer software for use in exclusively collecting, storing, controlling, managing and submitting of clinical metadata and clinical data in relation to clinical trials, database management computer software for use exclusively in relation to clinical trials, computer software to allow users to collect, store, control, manage and submit clinical metadata and clinical data in relation to clinical trials, computer databases for collecting, storing, controlling, managing and submitting clinical data in relation to clinical trials, computer software designed to ensure that clinical metadata and clinical data meets the regulations and standards required by international and government agencies in relation to clinical trials, computer software used by pharmaceutical companies, biotechnology companies, medical device manufacturers, and contract research organizations to help collect the required clinical data and meet the required standards for data collection, tabulation, analysis, and submission for clinical trials, all of the aforesaid computer software being used in relation to clinical trials only

Providing temporary use of on-line non-downloadable clinical metadata management computer software for use in relation to clinical trials; providing temporary use of on-line non-downloadable clinical management computer software for use in relation to clinical trials; providing temporary use of on-line non-downloadable computer software for use in exclusively collecting, storing, controlling, managing and submitting of clinical metadata and clinical data in relation to clinical trials; providing temporary use of on-line non-downloadable database management computer software for use exclusively in relation to clinical trials; providing temporary use of on-line non-downloadable computer software to allow users to collect, store, control, manage and submit clinical metadata and clinical data in relation to clinical trials; providing on-line computer databases for collecting, storing, controlling, managing and submitting clinical data in relation to clinical trials; providing temporary use of on-line non-downloadable computer software designed to ensure that clinical metadata and clinical data meets the regulations and standards required by international and government agencies in relation to clinical trials; providing temporary use of on-line non-downloadable computer software used by pharmaceutical companies, biotechnology companies, medical device manufacturers, and contract research organizations to help collect the required clinical data and meet the required standards for data collection, tabulation, analysis, and submission for clinical trials; design and development of computer software exclusively for managing clinical metadata and clinical data in clinical trials; designing, creating and maintaining web pages exclusively in connection with collecting, storing, controlling and managing clinical metadata and clinical data, to meet the regulations and standards required by international and government agencies in conducting clinical trials; all of the aforesaid software services being used in relation to clinical trials only; technical support services, namely, troubleshooting of computer software problems related to clinical metadata management software platforms for managing clinical trial metadata and clinical trial data; providing medical and scientific research information in the field of clinical trials to enable pharmaceutical companies, biotechnology companies, medical device manufacturers, and contract research organizations to collect the required clinical data and meet the regulations and standards required by international and government agencies for data collection, tabulation, analysis, and submission for clinical trials; technical support services, namely, troubleshooting of computer software problems related to clinical metadata management computer software for use in relation to clinical trials; technical support services, namely, troubleshooting of computer software problems related to clinical management computer software for use in relation to clinical trials; all of the aforesaid information and support services being used in relation to clinical trials only

Filing History

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
May 7, 2025 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 7, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
May 7, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 7, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 7, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 7, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 7, 2025 COAR
REGISTERED-PRINCIPAL REGISTER
Sep 14, 2021 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Aug 12, 2021 DP1B
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 12, 2021 AITU
NOTICE OF ALLOWANCE CANCELLED
Aug 3, 2021 IUCN
TEAS DELETE 1(B) BASIS RECEIVED
Aug 3, 2021 D1BR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 27, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 1, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jun 1, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 12, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 23, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 22, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 22, 2021 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 22, 2021 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 20, 2021 GNFN
FINAL REFUSAL E-MAILED
Apr 20, 2021 GNFR
FINAL REFUSAL WRITTEN
Apr 20, 2021 CNFR
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Mar 29, 2021 AMPX
TEAS VOLUNTARY AMENDMENT RECEIVED
Mar 29, 2021 PARI
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 9, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 9, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 3, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 22, 2020 GNRN
NON-FINAL ACTION E-MAILED
Dec 22, 2020 GNRT
NON-FINAL ACTION WRITTEN
Dec 22, 2020 CNRT
ASSIGNED TO EXAMINER
Dec 21, 2020 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Dec 2, 2020 AMPX
ASSIGNED TO LIE
Nov 30, 2020 ALIE
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 25, 2020 NWOS
TEAS VOLUNTARY AMENDMENT RECEIVED
Sep 14, 2020 PARI
NEW APPLICATION ENTERED
Aug 27, 2020 NWAP